Description
+ Include: 37 videos + 32 pdfs, size: 11.2 GB
+ Target Audience: medical oncologists, radiation oncologists, interventional radiologists, colorectal/hepatopancreatobiliary/oncologic surgeons, gastroenterologists, pathologists
+ Sample video: contact me for sample video
+ Information:
Friday, November 11, 2022, 8:00 AM – Saturday, November 12, 2022, 1:00 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY
This is a one-and-a-half-day live and virtual rectal cancer symposium will feature expert faculty from around the world.
Day 1 includes presentations that will delve into the complexities of choosing between neoadjuvant therapies and operative and non-operative approaches. The day will begin with the Stuart Quan lecture by Dr. Luis Diaz on the use of immunotherapy in CRC. This talk will be followed by sessions on 1) early-stage rectal cancer, 2) upper rectal cancer, 3) mid/lower rectal cancer, and 4) MSI and stage IV rectal cancer. Each session will be accompanied by interactive discussions with thought leaders and attendees.
Day 2 will include sessions with presentations highlighting recent landmark colorectal cancer clinical trials and real-life applications, including Niche, Dynamic, AINKER, and NeoTrial, by their investigators and discussed by expert faculty.
Who Should Attend
This symposium is intended for medical oncologists, radiation oncologists, interventional radiologists, colorectal/hepatopancreatobiliary/oncologic surgeons, gastroenterologists, pathologists, and other oncology care team members interested in rectal cancer.
- Describe the requirements for a successful, multidisciplinary rectal cancer program
- Explain recent updates and clinical trials in rectal cancer
- Identify appropriate candidates for Watch and Wait
+ Topics:
Colorectal2022Brochure.pdf
November 11 Assesment of Tumor Response- Practical Approach and Future Directions.mp4
November 11 Chemo First or Radiation First- Does It Really Matter.mp4
November 11 Chemo First or Radiation First- Does It Really Matter.pdf
November 11 Early Stage Disease – Case Presentation.mp4
November 11 Early Stage Disease – Case Presentation.pdf
November 11 Early Stage Disease – Panel Discussion.mp4
November 11 How Accurate is Preoperative Staging.mp4
November 11 How Accurate is Preoperative Staging.pdf
November 11 If So, Radiation or Chemotherapy.mp4
November 11 If So, Radiation or Chemotherapy.pdf
November 11 Individualizing Neoadjuvant Therapy.mp4
November 11 Individualizing Neoadjuvant Therapy.pdf
November 11 Is Neoadjuvant Therapy Necessary.mp4
November 11 Is Neoadjuvant Therapy Necessary.pdf
November 11 Is TME the Gold Standard.mp4
November 11 Is TME the Gold Standard.pdf
November 11 Managing Local Regrowth During Watch and Wait.mp4
November 11 Managing Local Regrowth During Watch and Wait.pdf
November 11 Managing the Rectal Primary When Treating the Metastatic Disease.mp4
November 11 Managing the Rectal Primary When Treating the Metastatic Disease.pdf
November 11 Mid Lower Rectal Cancer – Case Presentation.mp4
November 11 Mid Lower Rectal Cancer – Case Presentation.pdf
November 11 Mid Lower Rectal Cancer – Panel Discussion.mp4
November 11 MMR Deficient Colon and Rectal Cancers.mp4
November 11 MMR Deficient Colon and Rectal Cancers.pdf
November 11 Neoajuvant Therapy and Adaptive Treatment Based on Response.mp4
November 11 Neoajuvant Therapy and Adaptive Treatment Based on Response.pdf
November 11 Other Considerations – Case Presentation.mp4
November 11 Other Considerations – Case Presentation.pdf
November 11 Other Considerations – Panel Discussion.mp4
November 11 Short or Long Course Radiation- Techniques and The Evidence.mp4
November 11 Short or Long Course Radiation- Techniques and The Evidence.pdf
November 11 Targeted Therapy for Stage IV Disease.mp4
November 11 Targeted Therapy for Stage IV Disease.pdf
November 11 The Conondrum of the Enlarged Pelvic Lymph Nodes.mp4
November 11 The Conondrum of the Enlarged Pelvic Lymph Nodes.pdf
November 11 The Role of Local Excision in 2022.mp4
November 11 The Role of Local Excision in 2022.pdf
November 11 The Sequelae of Rectal Cancer Treatment.mp4
November 11 The Sequelae of Rectal Cancer Treatment.pdf
November 11 The Use of Endocavitary Radiation to Maximize Response.mp4
November 11 The Use of Endocavitary Radiation to Maximize Response.pdf
November 11 Treatment Escalation- Chemotherapy, Radiation, Radiosensitizers.mp4
November 11 Treatment Escalation- Chemotherapy, Radiation, Radiosensitizers.pdf
November 11 Treatment Options for Locally Recurrent Rectal Cancer.mp4
November 11 Treatment Options for Locally Recurrent Rectal Cancer.pdf
November 11 Upper Rectal Cancer – Case Presentation.mp4
November 11 Upper Rectal Cancer – Case Presentation.pdf
November 11 Upper Rectal Cancer – Panel Discussion.mp4
November 11 What is An Upper Rectal Cancer.mp4
November 11 What is An Upper Rectal Cancer.pdf
November 12 ANCHOR TRIAL – The Treatment of Anal HSIL Prevents Anal Cancer.mp4
November 12 ANCHOR TRIAL – The Treatment of Anal HSIL Prevents Anal Cancer.pdf
November 12 DYNAMIC TRIAL – ctDNA Guiding Adjuvant Therapy for Stage II Colon Cancer.mp4
November 12 DYNAMIC TRIAL – ctDNA Guiding Adjuvant Therapy for Stage II Colon Cancer.pdf
November 12 MOUNTAINEER TRIAL – HER2 Targeted Therapy.mp4
November 12 MOUNTAINEER TRIAL – HER2 Targeted Therapy.pdf
November 12 NEO TRIAL Neoadjuvant – Chemotherapy, Excision, and Observation for Early Stage Rectal Cancer.mp4
November 12 NEO TRIAL Neoadjuvant – Chemotherapy, Excision, and Observation for Early Stage Rectal Cancer.pdf
November 12 NEOADJUVANT IMMUNOTHERAPY TRIAL – Single Agent Neoadjuvant Immunotherapy Therapy for Rectal Cancer.mp4
November 12 NEOADJUVANT IMMUNOTHERAPY TRIAL – Single Agent Neoadjuvant Immunotherapy Therapy for Rectal Cancer.pdf
November 12 NICHE TRIAL – Neoadjuvant Immunotherapy for Colon Cancer.mp4
November 12 NICHE TRIAL – Neoadjuvant Immunotherapy for Colon Cancer.pdf
November 12 OPERA TRIAL – Contact X-Ray Brachytherapy with Chemoradiotherapy.mp4
November 12 OPERA TRIAL – Contact X-Ray Brachytherapy with Chemoradiotherapy.pdf
November 12 PARADIGM TRIAL – Pan vs. Bev in RAS wt, Left-sided Tumors.mp4
November 12 PARADIGM TRIAL – Pan vs. Bev in RAS wt, Left-sided Tumors.pdf
November 12 Results and Practical Applications of Recently Published Clinical Trials Q&A.mp4
Reviews
There are no reviews yet.